Citation

  • Authors: Hou, J., Lin, L., Zhou, W., Wang, Z., Ding, G., Dong, Q., Qin, L., Wu, X., Zheng, Y., Yang, Y., Tian, W., Zhang, Q., Wang, C., Zhuang, S. M., Zheng, L., Liang, A., Tao, W., Cao, X.
  • Year: 2011
  • Journal: Cancer Cell 19 232-43
  • Applications: in vitro / siRNA / INTERFERin
  • Cell type: Hep3B
    Description: Human hepatocellular carcinoma
    Known as: Hep3B

Abstract

The full scale of human miRNome in specific cell or tissue, especially in cancers, remains to be determined. An in-depth analysis of miRNomes in human normal liver, hepatitis liver, and hepatocellular carcinoma (HCC) was carried out in this study. We found nine miRNAs accounted for approximately 88.2% of the miRNome in human liver. The third most highly expressed miR-199a/b-3p is consistently decreased in HCC, and its decrement significantly correlates with poor survival of HCC patients. Moreover, miR-199a/b-3p can target tumor-promoting PAK4 to suppress HCC growth through inhibiting PAK4/Raf/MEK/ERK pathway both in vitro and in vivo. Our study provides miRNomes of human liver and HCC and contributes to better understanding of the important deregulated miRNAs in HCC and liver diseases.

Pubmed